DJ Eli Lilly & Co. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Eli Lilly & Co. $(LLY)$ slipped 2.01% to $911.06 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 1.22% to 5,778.15 and Dow Jones Industrial Average falling 1.55% to 42,520.99.
The stock's fall snapped a two-day winning streak.
Eli Lilly & Co. closed 6.32% below its 52-week high of $972.53, which the company achieved on August 22nd.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 1.11% to $165.42, Pfizer Inc. $(PFE)$ fell 1.90% to $25.75, and AbbVie Inc. $(ABBV)$ fell 1.76% to $207.76.
Trading volume (3.3 M) remained 379,495 below its 50-day average volume of 3.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 4, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 04, 2025 16:31 ET (21:31 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。